Report: Worldwide IVD Market Will Cross $60 Billion U.S. Dollars by 2014
Posted: August 20, 2012

A new Renub Research report titled “Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 – 2014)” examines the commercial prospects for IVD in the worldwide healthcare market. The report provides market landscape, competitive landscape, and market trends information on ten market categories, including molecular diagnostics, clinical chemistry, hematology, immunoassay, point-of-care testing, microbiology, histology/cytology, flow cytometry, blood screening typing, and coagulation. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. It also analyzes the past, present, and future forecast of the United States, Japan, Europe, India, China, and Taiwan IVD markets.

A sampling of report highlights:

• Globally, the IVD market will cross US$60 billion by 2014
• Point-of-care testing dominates the IVD market with more than 30% market share in 2009
• Molecular diagnostics is the fastest growing segment in the IVD market; its market share will reach approximately 18% by 2014  
• In 2009, Roche, Siemens, and Abbott Diagnostics together controlled 42% of the IVD market
• After point-of-care testing, immunoassay is the second largest market with a value of more than US$7 billion in 2009

 

Ivdt insight blog Tags:
»